Stockholders' Equity

6 Months Ended

Jul. 31, 2022

Equity [Abstract]

Stockholders' Equity

Note 7: Stockholders’ Equity

The Company has a stock-based compensation plan, the 2015 Equity Incentive Plan, pursuant to which it has granted incentive and nonstatutory stock options and restricted stock units. Additionally, the Company's 2015 Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of common stock at a discounted price through payroll deductions.

Stock Options. Stock option activity for the six months ended July 31, 2022 was as follows:

			Weighted-Average		Aggregate
	Shares		Exercise Price		Intrinsic Value
	(in thousands)		Per Share		(in thousands)
Balance as of January 31, 2022		1,325	$	8.93	$	12,064
Granted		95	$	16.69
Exercised		(48)	$	3.18
Balance as of July 31, 2022		1,372	$	9.67	$	4,473
Vested and exercisable as of July 31, 2022		1,151	$	8.62	$	4,404

The aggregate intrinsic value of vested options exercised during the six months ended July 31, 2022 and 2021 was $0.6 million and $0.8 million, respectively. The weighted-average grant date fair value of options granted during the six months ended July 31, 2022 and 2021 was $8.06 and $7.89 per share, respectively.

Restricted Stock Units. RSU activity for the six months ended July 31, 2022 was as follows:

	Shares (in thousands)		Weighted-Average Grant Date Fair Value Per Share
Balance as of January 31, 2022		1,312	$	15.05
Granted		940	$	16.42
Vested		(394)	$	14.87
Canceled		(38)	$	14.77
Balance as of July 31, 2022		1,820	$	15.81

Employee Stock Purchase Plan. During each of the six months ended July 31, 2022 and 2021, employees purchased 0.1 million shares at a weighted-average price of $10.22 and $10.07 per share, respectively.